ArticleCell stress & chaperones2016

Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes.

Dai Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.